Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)

NCT05684380 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
514
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

EMS